Man Group PLC : Form 8.3 - Strongbridge Biophar...
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1.
KEY
INFORMATION
| Name of person dealing (Note 1) | Man Group PLC/Jersey |
| Company dealt in | STRONGBRIDGE BIOPHARMA PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.01 ordinary shares |
| Date of dealing | 2021-09-10 |
2.
INTERESTS
AND
SHORT
POSITIONS
(a)
Interests
and
short
positions
(following
dealing)
in
the
class
of
relevant
security
dealt
in (Note 3)
| Long | Short | ||||||
| Number | (%) | Number | (%) | ||||
| (1) Relevant securities | 1,832,432.00 | 2.7015 | 0.00 | 0.00 | |||
| (2) Derivatives (other than options) | 0.00 | 0.00 | 0.00 | 0.00 | |||
| (3) Options and agreements to purchase/sell | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total | 1,832,432.00 | 2.7015 | 0.00 | 0.00 | |||
(b)
Interests
and
short
positions
in
relevant
securities
of
the
company,
other
than
the
class
dealt
in (Note 3)
| Class of relevant security: | Long | Short | ||||
| Number | (%) | Number | (%) | |||
| (1) Relevant securities | ||||||
|
(2) Derivatives (other than options) |
||||||
|
(3) Options and agreements to purchase/sell |
||||||
| Total | ||||||
Ap20
1.
DEALINGS (Note 4)
(a) Purchasesandsales
|
Purchase/sale |
Number of relevant securities |
Price per unit (Note 5) |
| Purchase | 104 | 2.25 |
| Purchase | 10,799 | 2.25 |
| Purchase | 83 | 2.25 |
(b)
Derivatives
transactions
(other
than
options
transactions)
|
Product
name,
e.g. CFD |
Nature
of
transaction
(Note 6) |
Number
of
relevant
securities
(Note 7) |
Price
per
unit
(Note 5) |
(c)
Options
transactions
in
respect
of
existing
relevant
securities
(i)
Writing,
selling,
purchasing
or
varying
|
Product
name,
e.g. call option |
Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
(ii)
Exercising
|
Product
name,
e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d)
Other
dealings
(including
transactions
in
respect
of
new
securities)
(Note
4)
|
Nature
of
transaction
(Note 8) |
Details |
Price
per
unit
(if applicable) (Note 5) |
Ap21
2.
OTHER
INFORMATION
Agreements,
arrangements
or
understandings
relating
to
options
or
derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) YES/NO
| Date of disclosure | 2021-09-13 |
| Contact name | Abdi Musse |
| Telephone number | +442071443164 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection (Note 10) |
COMPANIES COVERED:
Latest directors dealings
- 1 day ago Cerillion
- 1 day ago Associated British Foods
- 1 day ago B&M European Value Retail S.A. (DI)
- 1 day ago B&M European Value Retail S.A. (DI)
- 1 day ago Haleon